DOCSLIB.ORG

A Actigraphy, 33–45, 254, 255 Adjuvant Light Therapy, 152 Adrian

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Actigraphy, 33–45, 254, 255 Adjuvant Light Therapy, 152 Adrian Index A Berger, Johannes (Hans), 4, 21, 35, 36, 45 Actigraphy, 33–45, 254, 255 Biofeedback, 131, 165–180, 283 Adjuvant light therapy, 152 Biofeedback Certification International Adrian, Edgar Douglas, 21 Alliance (BCIA), 167 Adult attention deficit hyperactivity disorder Biosensor-monitoring techniques, 197 (ADHD), 41, 139, 155 Bipolar depression, 139, 145, 152–153 Advanced sleep phase disorder (ASPD), 254 Bipolar I Disorder, 150 Advanced sleep phase type (ASPT), 153, 154 Bipolar II Disorder, 150 Aging, 24, 143, 246, 249, 251, 257, 270 Blood-oxygen-level-dependent (BOLD) fMRI, Alpha rhythm, 21 209 Alzheimer’s disease, 10, 11, 138, 254 Blood volume pulse (BVP), 171 American Academy of Sleep Medicine BMAL, 211 (AASM), 23, 24, 58, 59, 111, 112, 117, Body sensor networks (BSN), 274 154, 264, 265 Brief Insomnia Screening Scale (BISS-C), 192, American Association of Sleep Disorders 193 (ASDA), 263, 264 Bright light therapy, 138, 145–155 Antepartum depression, 152 Bulimia nervosa, 139, 155 Antidepressant effect, 144–145, 149, 152 Burwell C. S., 25 Apnea/Hypopnea Index (AHI), 26, 58, 64, 91, Business model, 272, 273, 277, 280, 286 106, 107, 109–111, 113–117 Applied Psychophysiology and Biofeedback (AAPB), 166 C AR models, 10 Cardiovascular disorders, 57–58 Arousal system, 122, 123, 142, 143 Carskadon, Mary, 5, 26, 266 Aserinsky, Eugene, 5, 22 Caton, Richard, 20 Assessment, 9, 10, 33, 38–40, 78, 82, 114, 125, Cephalometry, 76 174, 187, 210, 245–257 Chronic depression, 152 ATP, 211 Circadian (Process C), 9 Autonomic nervous system (ANS), 124, 141, Circadian-related sleep disorder, 138 261 Circadian rhythm, 4, 5, 9, 10, 12, 33, 34, 38, Auto-titrating positive airway pressure 40, 43, 45, 123, 128, 131, 137–144, 148, (APAP), 60, 62–65 152–155, 186, 188, 253–254 Circadian rhythm sleep disorder (CRSD), 137, 139, 153–154, 253–254 B Circadian system, 122, 123, 125, 139, 186 Behavior therapy, 207 Clock, 122, 125, 137, 139–142, 152, 154, 188, Benzodiazepines, 44, 77, 250, 252 189, 196, 211, 254 R.P.-Y. Chiang and S.-C.J. Kang (eds.), Introduction to Modern Sleep Technology, 289 Intelligent Systems, Control and Automation: Science and Engineering 64, DOI 10.1007/978-94-007-5470-6, © Springer ScienceCBusiness Media Dordrecht 2012 290 Index Coccagna, Giorgio, 25 Expiratory pressure relief devices, 51, 60, 64 Cognitive-behavioral therapy (CBT), 151, 191, Eye and mouth detection, 223 194, 250 Cognitive behavioral treatment for insomnia (CBT-I), 121–133, 190, 249, 250 F Complex sleep apnea/treatment emergent Face determination, 223, 224, 228–229 central sleep apnea, 60 Face model, 224–226, 228, 231 Continuous positive airway pressure (CPAP), Facial expression, 220, 235 5, 27, 29, 43, 51–65, 106, 112, 114–118, Facial feature detection and tracking, 221, 225, 251, 252 235, 236, 239, 240 Core body temperature, 142, 150, 154, 254 Facial parameter estimation, 225, 229–231, Core circadian genes, 211 236–238 C-reactive protein (CRP), 212 Feng-Shui, 8 Critical closing pressure (Pcrit), 55–56 First night effect, 34 Cry, 211 Five sleep stages (A, B, C, D and E), 21 Cycling alternating pattern (CAP), 265 Four stages of non-REM(1–3, and 4), 23 Free-running type, 153 Functional residual capacity (FRC), 55 D Fuzzy reasoning, 224, 225, 233–234 Davis, Hallowell and Pauline, 21 Delayed sleep phase type (DSPT), 153, 154 Delta, 10, 24, 171, 265 G Delta model, 278, 280–282, 284, 285 GABAergic, 138, 142 Dement, William Charles, 5, 22, 23, 26, 263 Galvani, Luigi (or Aloysio), 20 Dorsomedial hypothalamic nucleus (DMH), Gamma-aminobutyric acid (GABA), 140–143 138, 141–143 Gastaut, Henri, 25, 262 Dorsomedial SCN (SCNdm), 140, 141 General biofeedback, 167 Drachman, D.B., 25 Geniculo-hypothalamic tract (GHT), 140, 141 Driver vigilance monitoring system, 223 Geomantic omen, 8 Driving behavior, 220, 241 Gerardy, Werner, 25 Drowsiness monitoring, 234 Global sleep dissatisfaction (GSD), 187 DuBois-Reynold, Emil, 20 Glutamate, 138, 140, 141, 143 Duron, Bernard, 25 Glutamatergic pathway, 140 Dysfunctional thought, 129 Golgi, Camillo, 20 Guilleminault, Christian, 26, 262, 263 Gumnit R. J., 25 E EDA, 220 H EEG biofeedback, 167, 176, 180 Harvey, E. Newton, 4, 21 Electrocardiography (ECG), 201, 204–205 Heart rate variability (HRV), 6, 171, 175, 176, Electroencephalogram (EEG), 4, 21, 166, 171, 196, 197, 204 174, 179, 180, 201–203 Hobart III, Garret, 21 Electroencephalography biofeedback, 171, Holland, Jerome, 26 179, 180 Homeostatic (Process S), 9 Electromyography (EMG), 166, 169–170, Homeostatic system, 122, 123 172–174, 178–180, 203–204 Horne-Ostberg¨ Morningness–Eveningness Electrooculogram (EOG), 22, 201, 205–206 Questionnaire, 148 Electrophysiological method, 205 Human serum albumin (HSA), 213 Empirically supported treatment (EST), 173 Hybrid analysis, 273, 278, 282, 286 Endoscopy, 73, 75 Hyperarousal, 123, 177 Engineering, 13, 179, 180, 190 Hypersomnia, 144, 150, 247 Excessive daytime sleepiness (EDS), 25, 26, Hypnos, 20 29, 52, 65, 186, 251, 252 Hypnotic, 122, 128, 143, 250, 251, 256, 262 Index 291 I Lugaresi, Elio, 25, 262 Illuminance, 146, 147, 149 Lux, 138, 142–151, 154, 155 Indoor air quality (IAQ), 186 Industrial design, 13, 190 Infrared (IR), 221, 241 M Insomnia, 4, 8, 33–36, 38–40, 44, 45, 58, 62, Magnetic resonance imaging (MRI), 79, 208, 121–133, 143, 154, 165–180, 186, 187, 209 190–194, 199, 207, 246–250, 257, 262, Maintenance Wakefulness Test (MWT), 26, 266 29, 57 Insomniac, 193 Major depressive episode, 150, 155 Intensity, 9, 38, 109, 110, 132, 139, 142, 143, Management, 5, 6, 13, 41, 51–65, 71–100, 145–148, 152, 154, 186, 188, 189, 240 105–118, 121–133, 137–155, 165–180, Interdisciplinary cooperation, 4 245–257, 273, 281 International Society for Neurofeedback & Maxillomandibular advancement (MMA), 84, Research (ISNR), 167 91, 92, 95 Internet-based self-help CBT-I treatment, 132 Melatonin, 40, 43, 138, 139, 141–144, 148, Irregular sleep wake disorder (ISWD), 254 150, 151, 155, 250, 253, 254 Irregular sleep-wake phase type, 153 Monoamine hypothesis, 144 Monoamine oxidase inhibitors (MAOI), 144 Morpheus, 20 Movement disorder, 24, 34, 44, 247 J Multi-factorial geriatric syndrome, 246 Jet lag, 138, 153, 154 Multiple sleep latency test (MSLT), 5, 26, 29, Jet lag type, 153 57 Johannes Berger, 4 Journal of Behavioral Medicine, 166 Jouvet, Michel Valentin Marcel, 23, 262 N Jung, R, 25 Narcolepsy, 23, 263 Near-infrared (NIR), 82, 221, 241 Negative pressure upper airway reflex, 52–53 K Neurofeedback, 167, 172, 176–180 Kales, Anthony, 5, 23, 264 Neuropeptide pituitary adenylate cyclase- Kalman filter, 223 activating protein (PACAP), 140, Kleitman, Nathaniel, 5, 21–23 141 Krieger, Jean, 26 Neuropeptide Y (NPY), 140, 141 Kuhlo, W, 25 Noise, 6–8, 62, 64, 79, 155, 169, 170, 186, Kurtz, Daniel, 26 199, 203, 212, 255, 256 Non-REM sleep, 9, 21, 23, 110, 206, 207, 265 Non-seasonal depression, 138, 139, 147, 151–152 L Non-seasonal mood disorders, 138 Late luteal phase dysphoric disorder, 139 Number of nocturnal awakening (NWAK), 34, Lateral geniculate, 140 42 Light box, 146 Nursing home, 42, 43, 155, 255, 256 Light deprivation, 144 Nyx, 20 Light emitting diodes (LEDs), 149, 151, 171, 188, 220 Light therapy, 131–132, 137–155, 188, 249, O 254 Obesity-hypoventilation syndrome, 25 Light visor, 146 Objective measures, 26, 38, 45, 210 Linear discriminate function (LDF), 39 Obstructive sleep apnea, 5, 26, 52, 71–82, 99, Locus coeruleus (LC), 23, 143, 144 105, 117, 204, 248, 251 Long-term care, 5, 12, 246, 255, 256 Obstructive sleep apnea syndrome (OSAS), 56, Loomis, Alfred Lee, 4, 21 84, 96, 105–109, 112, 204, 207–209, Loop gain, 54, 55 211, 212, 248, 251, 254, 256 292 Index Older adults, 42–43, 121, 245–257 Rechtschaffen and Kales (R&K) system, 23, Optima moisture model, 7 24, 264 Orexin (hypocretin), 138, 142, 143 Relative humidity (RH), 7, 186 Oscillating behavior, 139 Relaxation training, 127, 128, 131, 177, 191 REM sleep. See Rapid eye movement (REM) sleep P Respiratory-event-related-arousal (RERA), 59, Paradoxical sleep, 23 264 Parasomnia, 36, 247, 253 Respiratory sinus arrhythmia (RSA), 173–177, Paraventricular hypothalamic nucleus (PVH), 179 141–143 Response surface analysis, 113 Pelvic muscle dysfunction biofeedback, 167 Restless legs syndrome (RLS), 25, 43, 248, Pervasive health care, 269–287 252–254, 256, 257 Phase-response curve (PRC), 142, 154 Retinal ganglion cells, 139, 140 Phase shift, 132, 138, 142–144, 146, 150 Retino-hypothalamic tract (RHT), 138, 140, Phase-shift hypothesis (PSH), 144 141 Phototherapy, 138, 144, 150 Retinorecipient structure, 140 Physiological response, 220 Pickwickian syndrome, 25, 262 Pieron,´ Henri, 20 S Pillar implants, 87, 99, 100 Seasonal affective disorder (SAD), 138, 139, Polarity, 169, 171 143, 144, 147, 150, 153 Polysomnography (PSG), 5–7, 19–30, 34, 35, Self-regulation skills, 176, 177 38, 39, 41, 43–45, 56, 59, 63–65, 75, 79, Sensorimotor rhythm (SMR), 171, 176–178 80, 82, 84, 106, 178, 201–206, 209, 220 Serotonergic (5-HT), 140, 144 Porter’s five forces, 278–280, 282, 284, 285 Shift work, 45, 138, 139, 143, 153, 154 Positional Therapy, 105–118 Shift work type, 153 Positron emission tomography (PET), 123, Short EEG arousal, 264 206–209 Sigma band, 171 Postpartum depression, 152 Single-photon emission computed tomography Preoptic nucleus, 138, 142, 143 (SPECT), 207, 209 Primary sleep disorder, 257 Skin conductance level (SCL), 196, 197 Progressive muscle relaxation (PMR), 128, Skin location, 223 131, 173, 174, 176, 191 Skin model, 223, 225–226 Proportional integrating measure (PIM), 38 Sleep apnea, 5, 26, 38, 52, 54, 56, 58, 60–61, Prostate-specific
Load more

Recommended publications
  • The Evidence-Base for Neurofeedback As a Reimbursable Healthcare Service to Treat Attention Deficit/Hyperactivity Disorder
    The Evidence-Base for Neurofeedback as a Reimbursable Healthcare Service to Treat Attention Deficit/Hyperactivity Disorder By H. Edmund Pigott, Ph.D.,a Lindsay De Biase, Ph.D.,b c d Eugenia Bodenhamer-Davis, Ph.D. & Richard E. Davis, M.S. a Ed Pigott, Ph.D. is a licensed psychologist and Director of Neurotherapy Services at Behavioral Health of the Palm Beaches. He is also in private practice at The Center for Brain Training in Jupiter, FL. b Lindsay De Biase, Ph.D. is a neuroscientist and post-doctoral fellow. C Eugenia Bodenhamer-Davis, Ph.D. is an Associate Professor and Director, Neurotherapy Program, University of North Texas and a Board member of the Biofeedback Certification International Alliance. D Richard E. Davis, M.S. is a Licensed Professional Counselor in private practice in Denton, TX, specializing in neurofeedback and Quantitative EEG. He is also a Past President of the International Society of Neurofeedback and Research. Acknowledgements: Preparation of this white paper was guided by extensive discussion and critical review from Henry Harbin with assistance from Thomas Bearden and Robert Thatcher along with the invaluable help from Alexei Berd in securing articles for review. The authors would like to thank the Board of the International Society of Neurofeedback and Research for their support of this project. 1 Table of Contents Executive Summary 3 An Overview of Neurofeedback Practice 6 The Inadequacy of Current ADHD Treatments 8 Neurofeedback: The Operant Conditioning of Trainees’ EEG 12 Neurofeedback: An Evidence-Based
    [Show full text]
  • An Exploration of Physiological Responses to the Native American Flute
    An Exploration of Physiological Responses to the Native American Flute Eric B. Miller† and Clinton F. Goss‡ †Montclair State University, Montclair, New Jersey; Email: [email protected] ‡Westport, Connecticut; Email: [email protected] ARTICLE INFORMATION ABSTRACT Presented at ISQRMM, Athens, This pilot study explored physiological responses to playing and listening to the GA: July 26, 2013 Native American flute. Autonomic, electroencephalographic (EEG), and heart Revised: January 24, 2014 rate variability (HRV) metrics were recorded while participants (N = 15) played flutes and listened to several styles of music. Flute playing was accompanied by This work is licensed under the an 84% increase in HRV (p < .001). EEG theta (4–8 Hz) activity increased while Creative Commons Attribution- playing flutes (p = .007) and alpha (8–12 Hz) increased while playing lower- Noncommercial 3.0 license. pitched flutes (p = .009). Increase in alpha from baseline to the flute playing This work has not been peer conditions strongly correlated with experience playing Native American flutes (r reviewed. = +.700). Wide-band beta (12–25 Hz) decreased from the silence conditions when listening to solo Native American flute music (p = .013). The findings of increased HRV, increasing slow-wave rhythms, and decreased beta support the hypothesis that Native American flutes, particularly those with lower pitches, may have a role in music therapy contexts. We conclude that the Native Keywords: music therapy, American flute may merit a more prominent role in music therapy and that a Native American flute, heart rate variability (HRV), study of the effects of flute playing on clinical conditions, such as post-traumatic EEG, alpha stress disorder (PTSD), asthma, chronic obstructive pulmonary disease (COPD), hypertension, anxiety, and major depressive disorder, is warranted.
    [Show full text]
  • Enhancing the Effects of Neurofeedback Training: the Motivational Value of the Reinforcers
    brain sciences Article Enhancing the Effects of Neurofeedback Training: The Motivational Value of the Reinforcers Rubén Pérez-Elvira 1 , Javier Oltra-Cucarella 2,* , José Antonio Carrobles 3, Jorge Moltó 4, Mercedes Flórez 4, Salvador Parra 5, María Agudo 1, Clara Saez 1, Sergio Guarino 6, Raluca Maria Costea 7,8 and Bogdan Neamtu 7,8,9 1 Neuropsychophysiology Laboratory, NEPSA Rehabilitación Neurológica, 3003 Salamanca, Spain; [email protected] (R.P.-E.); [email protected] (M.A.); [email protected] (C.S.) 2 Department of Health Psychology, Universidad Miguel Hernández de Elche, 03202 Elche, Spain 3 Biological and Health Psychology Department, Universidad Autónoma de Madrid, 28049 Madrid, Spain; [email protected] 4 PSYD-Neurofeedback, 46022 Valencia, Spain; [email protected] (J.M.); [email protected] (M.F.) 5 LURIA Rehabilitación Neurológica, 11407 Jerez, Spain; [email protected] 6 NEPSA Rehabilitación Neurológica, 47001 Valladolid, Spain; [email protected] 7 Research Department (Ceforaten), Sibiu Pediatric Hospital, 550178 Sibiu, Romania; [email protected] (R.M.C.); [email protected] (B.N.) 8 Faculty of Medicine Lucian Blaga, University from Sibiu, 550169 Sibiu, Romania 9 Faculty of Engineering, Lucian Blaga, University from Sibiu, 550025 Sibiu, Romania * Correspondence: [email protected] Abstract: The brain activity that is measured by electroencephalography (EEG) can be modified through operant conditioning, specifically using neurofeedback (NF). NF has been applied to several disorders claiming that a change in the erratic brain activity would be accompanied by a reduction Citation: Pérez-Elvira, R.; of the symptoms. However, the expected results are not always achieved. Some authors have Oltra-Cucarella, J.; Carrobles, J.A.; suggested that the lack of an adequate response may be due to an incorrect application of the operant Moltó, J.; Flórez, M.; Parra, S.; conditioning principles.
    [Show full text]
  • Download Download
    NeuroRegulation http://www.isnr.org The Effect of Infraslow Frequency Neurofeedback on Autonomic Nervous System Function in Adults with Anxiety and Related Diseases Karlien Balt1*, Peet Du Toit1, Mark Smith2, and Charl Janse van Rensburg3 1Department of Human Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa 2Neurofeedback Services of New York, New York, New York, USA 3South African Medical Research Council, Biostatistics Unit, Pretoria, South Africa Abstract Peripheral body monitoring of autonomic nervous system (ANS) response has been routinely applied during infraslow fluctuation (ISF) neurofeedback training. This study hypothesized that ISF training has a distinct physiological effect on an individual that can be revealed by measuring autonomic function with peripheral biofeedback metrics that included heart rate variability (HRV), muscle tension, skin temperature, skin conductance, heart rate, respiration rate, and blood pressure. Methods. Thirty adults between the ages of 18 and 55, primarily with anxiety, were randomized into two groups: 20 in the experimental group and 9 in the control group. The experimental group completed 10 ISF neurofeedback training sessions while continuous monitoring of ANS changes was applied. The same process was completed for a control group that received one-channel sensorimotor rhythm (SMR) neurofeedback training. Results. Significant changes were seen in the skin conductance (p < .0001), electromyography (p = .01), very low frequency (p = .004), low frequency of HRV (p = .05) and blood pressure (systolic change p = .049) in the experimental group. No significant changes were seen in the control group. Conclusion. The study demonstrated that ISF neurofeedback training impacts the ANS as measured by peripheral biofeedback indicators.
    [Show full text]
  • ESRS Final Programme
    DISCOVER ALICE PDx AT THE RESPIRONICS STAND 8 DURING ESRS 2008 ALICE PDx: FREE YOUR PORTABLE SLEEP-SCORING! Alice PDx is the new advanced portable sleep diagnostic device from Respironics. Designed for portable diagnosis of cardio-repiratory sleep disorders, providing safe, efficient and easy sleep-scoring capacity for your sleep lab. With its intuitive interface and novel ‘Good Study Indicator’, Alice PDx provides unique and timely insights into the results of studies, reducing sleep technologists time and limiting unnecessary transportation From advanced polygraphy, adding the sleep-scoring options, a total of 5 ECG electrodes, 4 total ‘Neuro’ (EEG/EOG) inputs, plus 3 total EMG’s can also be connected allowing ambulatory sleep-scoring. AlicePDx oday is a service mark of Respironics Inc. and its affiliates. Improving T Envisioning tomorrow. Improving today. +33.1.47.52.30.00. WWW.RESPIRONICS.EU ©2008 Respironics, Inc. and its affiliates. All rights reserved. Respironics, Alice are trademarks of Respironics Inc. and its affiliates. Envisioning tomorrow CONTENTS Committees . 2 Acknowledgements . 3 Welcome . 4 Orientation Guide . 6 General Information . 7 Programme Overview . 11 Programme - Tuesday, 9 September . 17 Programme - Wednesday, 10 September . 19 Programme - Thursday, 11 September . 24 Programme - Friday, 12 September . 33 Programme - Saturday, 13 September . 42 Posters . 50 Exhibition Floor Plan . 87 Sponsor Details . 88 Exhibition Catalogue . 90 Social Programme . 99 Tour Programme . 100 1 COMMITTEES EUROPEAN SLEEP RESEARCH SOCIETY
    [Show full text]
  • Dystonia with Parkinson's Disease): Theory and Preliminary Results Michael Thompson MD a & Lynda Thompson Phd B a ADD Centres Ltd
    Journal of Neurotherapy: Investigations in Neuromodulation, Neurofeedback and Applied Neuroscience Biofeedback for Movement Disorders (Dystonia with Parkinson's Disease): Theory and Preliminary Results Michael Thompson MD a & Lynda Thompson PhD b a ADD Centres Ltd. , Mississauga, Ontario, Canada b The ADD Centre , Mississauga, Toronto, Ontario, Canada Published online: 08 Sep 2008. To cite this article: Michael Thompson MD & Lynda Thompson PhD (2002) Biofeedback for Movement Disorders (Dystonia with Parkinson's Disease): Theory and Preliminary Results, Journal of Neurotherapy: Investigations in Neuromodulation, Neurofeedback and Applied Neuroscience, 6:4, 51-70 To link to this article: http://dx.doi.org/10.1300/J184v06n04_06 PLEASE SCROLL DOWN FOR ARTICLE © International Society for Neurofeedback and Research (ISNR), all rights reserved. This article (the “Article”) may be accessed online from ISNR at no charge. The Article may be viewed online, stored in electronic or physical form, or archived for research, teaching, and private study purposes. The Article may be archived in public libraries or university libraries at the direction of said public library or university library. Any other reproduction of the Article for redistribution, sale, resale, loan, sublicensing, systematic supply, or other distribution, including both physical and electronic reproduction for such purposes, is expressly forbidden. Preparing or reproducing derivative works of this article is expressly forbidden. ISNR makes no representation or warranty as to the accuracy or completeness of any content in the Article. From 1995 to 2013 the Journal of Neurotherapy was the official publication of ISNR (www. Isnr.org); on April 27, 2016 ISNR acquired the journal from Taylor & Francis Group, LLC. In 2014, ISNR established its official open-access journal NeuroRegulation (ISSN: 2373-0587; www.neuroregulation.org).
    [Show full text]
  • Higher Power of Sensorimotor Rhythm Is Associated with Better Performance in Skilled Air-Pistol Shooters
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Publications at Bielefeld University Psychology of Sport and Exercise 32 (2017) 47e53 Contents lists available at ScienceDirect Psychology of Sport and Exercise journal homepage: www.elsevier.com/locate/psychsport Higher power of sensorimotor rhythm is associated with better performance in skilled air-pistol shooters Ming-Yang Cheng a, b, Kuo-Pin Wang c, Chiao-Ling Hung d, Yu-Long Tu c, * Chung-Ju Huang e, Dirk Koester a, b, Thomas Schack a, b, Tsung-Min Hung c, a Center of Excellence “Cognitive Interaction Technology” (CITEC), Bielefeld University, Inspiration 1, 33619, Bielefeld, Germany b Neurocognition and Action - Biomechanics Research Group, Faculty of Psychology and Sports Science, Bielefeld University, Universitatsstraße€ 25, 33615, Bielefeld, Germany c Department of Physical Education, National Taiwan Normal University, No. 162 Heping East Road Section 1, Da-an District, Taipei 106, Taiwan d Department of Athletics, National Taiwan University, No. 1, Sec. 4, Roosevelt Rd., Taipei 10617, Taiwan e Graduate Institute of Sport Pedagogy, University of Taipei, No.101, Sec. 2, Zhongcheng Rd., Shilin Dist., Taipei, Taiwan article info abstract Article history: Objectives: Psychomotor efficiency has been linked with processing efficiency during sport performance. Received 5 December 2016 Reduced cortical activity in the sensorimotor area has been related to less variability in the movement Received in revised form preparation that is conducive to skilled motor performance. This study proposes sensorimotor rhythm 31 May 2017 (SMR), 12e15 Hz of the electroencephalography (EEG) in the sensorimotor area, may be used to inves- Accepted 31 May 2017 tigate psychomotor efficiency in sports performance.
    [Show full text]
  • Physiological Origins and Functional Correlates of EEG Rhythmic Activities: Implications for Self-Regulation I
    Biofeedback and Self-Regulation, Vol. 21, No. I, 1996 Physiological Origins and Functional Correlates of EEG Rhythmic Activities: Implications for Self-Regulation I M. Barry Sterman 2 Veterans Administration Medical Center Sepulveda, and School of Medicine, University of California, Los Angeles Recent neurophysiologicat findings in relation to thalamocorticat mechanisms for sensory processing, together with established anatomical and expanding functional evidence, have provided a rational theoretical framework for the interpretation of normal and abnormal EEG rhythmic activities. This perspective is integrated here with earlier animal studies which were the foundation for many current applications of EEG self-regulation as a clinical tool. Basic evidence concerning the origins, frequency modulation, and fimctional significance of normal EEG rhythmic activities is reviewed here in an effort to provide guiding principles for the interpretation of clinical abnormalities and their remediation with EEG feedback training. Descriptor Key Words: EEG; thalamic circuits; SMR; event-related responses; epilepsy; ADHD; ADD; substance abuse. Although much has been learned through basic research about the under- lying neural mechanisms and functional correlates of rhythmic EEG activi- 1The author wishes to thank the many colleagues whose work and collaboration have contributed to the concepts discussed in this review. In particular, I would like to express my sincere appreciation to Drs. Wanda Wyrwicka, Scott Bowersox, Margaret Shouse, William Kuhlman, Allen Wyler, Ronald Szymusiak, and David Kaiser. I would also like to thank Mrs. Jerri Kaiser for her assistance in the preparation of this manuscript. The work presented here from my laboratory has been supported by the Veterans Administration, the National Institutes of Health, the U.S.
    [Show full text]
  • Neurofeedback for Insomnia: a Pilot Study of Z-Score SMR and Individualized Protocols Barbara U. Hammer, Agatha P. Colbert, Kimb
    Neurofeedback for Insomnia: A Pilot Study of Z-Score SMR and Individualized Protocols Barbara U. Hammer, Agatha P. Colbert, Kimberly A. Brown & Elena C. Ilioi Applied Psychophysiology and Biofeedback In association with the Association for Applied Psychophysiology and Biofeedback ISSN 1090-0586 Appl Psychophysiol Biofeedback DOI 10.1007/s10484-011-9165- y 1 23 Your article is protected by copyright and all rights are held exclusively by Springer Science+Business Media, LLC. This e-offprint is for personal use only and shall not be self- archived in electronic repositories. If you wish to self-archive your work, please use the accepted author’s version for posting to your own website or your institution’s repository. You may further deposit the accepted author’s version on a funder’s repository at a funder’s request, provided it is not made publicly available until 12 months after publication. 1 23 Author's personal copy Appl Psychophysiol Biofeedback DOI 10.1007/s10484-011-9165-y Neurofeedback for Insomnia: A Pilot Study of Z-Score SMR and Individualized Protocols Barbara U. Hammer • Agatha P. Colbert • Kimberly A. Brown • Elena C. Ilioi Ó Springer Science+Business Media, LLC 2011 Abstract Insomnia is an epidemic in the US. Neuro- Pittsburgh Sleep Quality Inventory (PSQI p \ .0001), PSQI feedback (NFB) is a little used, psychophysiological treat- Sleep Efficiency (p \ .007), and Quality of Life Inventory ment with demonstrated usefulness for treating insomnia. (p \ .02). Binomial tests of baseline EEGs indicated a Our objective was to assess whether two distinct Z-Score significant proportion of excessively high levels of Delta NFB protocols, a modified sensorimotor (SMR) protocol and Beta power (p \ .001) which were lowered post- and a sequential, quantitative EEG (sQEEG)-guided, indi- treatment (paired z-tests p \ .001).
    [Show full text]
  • Clinical Findings in SMR Neurofeedback Protocol Training in Women with Fibromyalgia Syndrome
    brain sciences Article Clinical Findings in SMR Neurofeedback Protocol Training in Women with Fibromyalgia Syndrome Carlos Barbosa-Torres 1,* and Sixto Cubo-Delgado 2 1 Department of Psychology, University of Extremadura, 10003 Cáceres, Spain 2 Department of Educational Sciences, University of Extremadura, 06006 Badajoz, Spain; [email protected] * Correspondence: [email protected] Abstract: Fibromyalgia is related to central sensitization syndrome (CSS) and is associated with chronic pain and a decrease in general health. The aim of this study was to explore how changes in brain patterns of female fibromyalgia patients are shaped by neurofeedback therapy and how it affects pain perception and general health. A quasi-experimental study with pre- and post-tests was carried out with 37 female fibromyalgia patients referred by the Pain Unit of the National Health Service of Spain. The method involved applying a sensorimotor rhythm (SMR) protocol to monitor changes in brain waves under different conditions, taking pre-/post-test measurements of perceived pain, general health and the impact on fibromyalgia. Measures included the Fibromyalgia Impact Questionnaire Revised (FIQR), the Visual Analogue Scale (VAS), the General Health Questionnaire (GHQ-28) and EEG (SMR, theta waves). During therapy, the SMR/theta wave ratio increased significantly and after application of therapy, significant results were observed for the FIQR, VAS and GHQ-28. In conclusion, neurofeedback therapy increases the SMR/theta wave ratio in fibromyalgia, helping to maintain a balance between brain functions. This is associated with the activation of inhibitory processes, which is related to the perceived improvement of pain in fibromyalgia patients. Citation: Barbosa-Torres, C.; Cubo-Delgado, S.
    [Show full text]
  • Neuroregulation
    To appear in "APPLIED NEUROPHYSIOLOGY & BRAIN BIOFEEDBACK" Edited by Rob Kall, Joe Kamiya, and Gary Schwartz EEG Biofeedback: A Generalized Approach to Neuroregulation By Siegfried Othmer, Susan F. Othmer, and David A. Kaiser Overview Many clinicians who have adopted EEG biofeedback are struck by the wide variety of clinical indications for which efficacy has been either observed directly, or claimed by others. This chapter presents a comprehensive overview of the current state of EEG biofeedback from the clinical perspective, but with an orientation toward model building. Specifically, the review covers the higher frequency training conventionally referred to as "SMR/beta" (nominally 12 to 19 Hz). Discussion of the lower frequency domain of "alpha/theta" (4 to 12 Hz), though of great interest as well, is left to others. First, a conceptual model is proposed and discussed. Second, the research history of the field is drawn upon to illustrate the evolution of protocols and explain elements of the emerging model. Third, an overview of our clinical results is given that depicts the use of the proposed "generalized approach" for a number of mental disorders. These results were obtained with a relatively limited set of clinical protocols that evolved out of our extrapolation of new methods from the original research. From these results emerges a need to explain how such broad efficacy can be achieved. It is postulated that the EEG feedback technique not only promotes particular functional states of the brain, but more generally exercises neural mechanisms by which the fundamental functions of arousal, attention and affect are managed by the central nervous system (CNS).
    [Show full text]
  • Brainwave Entrainment - a New Way for Relaxation and Healing Has Right Or Left Hemisphere Dominance
    24/07/2019 Brainwave Entrainment - A new way for relaxation and healing has right or left hemisphere dominance. Understanding Brainwaves In order to understand why brainwave entrainment is successful for achieving relaxation, reducing anxiety, and aiding in so many other ways, understanding brainwaves is essential. The brain is composed of millions of specialized cells called neurons. Neurons send signals to other neurons using electro- chemical messengers called neuro-transmitters that attach to receiving sites located on the neurons themselves. There is a space between the end of the neuron and the receptor called the synaptic gap. As neuro-transmitter chemicals move across this gap, a small electrical charge is created. These myriad chemical interactions occurring all over the brain at the same time produces electrical waves of specific frequencies that can be detected at the surface of the skull and are called neural oscillations or brainwaves. Brainwaves change and vary in frequency depending on what activities we are doing with slower waves being produced during sleep and faster waves occurring during periods of activity and mental focus. Everyone has all forms of brainwaves in different amounts and at different times. While a practical understanding of brainwaves has been around for as long as people have been singing, chanting, and drumming, a scientific view of the electrical activity inside the human brain was not published until 1924 when German psychiatrist Hans Berger developed a machine for sensing and recording activity in the brain by attaching small electrical sensors to the scalp of his patients and recording the resulting electrical activity. Berger’s inventions and discoveries were built upon the earlier work of Richard Caton who published animal studies on brainwave oscillations in 1875.
    [Show full text]